A comparison of danofloxacin and tylosin in the control of induced Mycoplasma gallisepticum infection in broiler chicks.
Experimental mycoplasmosis was induced in 1-day-old chicks by intrapulmonary inoculation of Mycoplasma gallisepticum (MG). This method of infection proved to be useful for evaluating the efficacy of antimicrobial medication, by measuring mortality, weight gain, pathological responses, frequency of reisolation of MG, and seroconversion. Using this model, the efficacies of danofloxacin (a novel fluoroquinolone) and tylosin were compared for two MG isolates, a reference isolate (the R-strain) and a field isolate from California. Danofloxacin administered in the water at 50 ppm for 3 days was equivalent to tylosin at 500 ppm for 3 days in the degree of control of mortality and maintenance of weight gain. Danofloxacin was superior to tylosin in preventing air-sac lesions, reducing the frequency of reisolation of MG, and preventing seroconversion in surviving birds.
Central Research Division, Pfizer Inc., Terre Haute, Indiana 47808.
A C
AC
Tanner
A P
AP
Avakian
H J
HJ
Barnes
D H
DH
Ley
T T
TT
Migaki
R A
RA
Magonigle
D000400:Air Sacs; D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002645:Chickens / Q000382:microbiology*; D024841:Fluoroquinolones; D008297:Male; D009174:Mycoplasma / Q000302:isolation & purification; D009175:Mycoplasma Infections / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control / Q000662:veterinary*; D011201:Poultry Diseases / Q000382:microbiology / Q000401:mortality / Q000517:prevention & control*; D015363:Quinolones / Q000627:therapeutic use*; D015645:Tylosin / Q000627:therapeutic use*; D015430:Weight Gain
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C068581:danofloxacin; D015645:Tylosin